Slow-wave sleep and daytime functioning in chronic fatigue syndrome: effects of sodium oxybate

Trial Profile

Slow-wave sleep and daytime functioning in chronic fatigue syndrome: effects of sodium oxybate

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jan 2016

At a glance

  • Drugs Sodium oxybate (Primary)
  • Indications Chronic fatigue syndrome
  • Focus Therapeutic Use
  • Acronyms SAFFE
  • Most Recent Events

    • 26 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Jul 2015 Accrual to date is 241 % according to United Kingdom Clinical Research Network record.
    • 05 May 2015 Planned End Date changed from 30 Apr 2015 to 31 Aug 2015 as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top